Hi Graham,
Resistance can often be caused by a mutation of BCR-Abl, meaning imatinib is less effective against it thus seeing a spike in your numbers. Since you have gone above 0.1%, your doctor is right to do something about this. Guidelines (ELN) would steer towards changing TKI if you lost MMR (0.1%) and it was confirmed by two tests.
The ultimate test for a mutation, as I understand it, would be done via cytogenetics - i.e. a bone marrow test. However, this is often not done prior to switching drug. The reason is that the second generation drugs are usually effective against mutations other than T315i, which is rare. So, there's a certain logic just to change drug rather than go through a bone marrow test to look at what particular mutation you might have only to prescribe the same 2nd generation TKI you were going to, anyway.
In the mast majority of cases, the 2nd generation TKI will bring you back into MMR.
On the point of accelerated phase, this is usually defined as a certain level of blast cells in your blood. With a PCR of 0.28, you won't be in that position.
David.